Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.11 billion
P/E Ratio 294.32
Dividend Yield 0.75%
Shares Outstanding 1.63 billion
Earnings per share 0.014
Dividend per share 0.01
Year To Date Return 28.86%
Earnings Yield 0.34%
Franking 50
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    Woman looks amazed and shocked as she looks at her laptop.
    Share Gainers

    Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

    These shares are having a good session on hump day. But why?

    Read more »

    A young woman wearing a blue and white striped t-shirt blows air from her cheeks and looks up and to the side in a sign of disappointment after the ASX shares she owns went down today
    Share Market News

    Why Arafura, Pentanet, Sigma, and Webjet shares are falling today

    These shares are ending the week in the red. But why?

    Read more »

    a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
    Share Gainers

    Why Australian Strategic Metals, Evolution, Sigma, and Webjet shares are storming higher

    These ASX shares are having a very strong session. But why>

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Earnings Results

    Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

    This could be the last set of results from Sigma as we know it if its merger is approved.

    Read more »

    A player pounces on the ball in the scoring zone of the field.
    Investing Strategies

    'Start building a position': 3 ASX shares to pounce on right now

    Inflation and interest rates might be on everyone's minds this week, but experts reckon this trio is looking good no…

    Read more »

    Scientists working in the laboratory and examining results.
    Share Market News

    2 ASX healthcare shares with 'significant growth opportunities'

    This fund manager has named revealed some healthy opportunities.

    Read more »

    A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
    Share Fallers

    Why Azure Minerals, Brainchip, Core Lithium, and Sigma shares are falling

    These ASX shares are starting the week in the red.

    Read more »

    A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
    Share Fallers

    Why Australian Clinical Labs, Meridian, MyState, and Sigma shares are falling today

    These ASX shares are ending the week in the red. But why?

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why BlueScope, Fortescue, Polynovo, and Sigma shares are racing higher

    These ASX shares are having a strong session on hump day. But why?

    Read more »

    Female pharmacist smiles with a digital tablet.
    Healthcare Shares

    When will Chemist Warehouse shares be trading on the ASX?

    A $9 billion monster is being created but when can you invest?

    Read more »

    A senior pharmacist talks to a customer at the counter in a shop
    Retail Shares

    Could Chemist Warehouse's ASX listing impact Wesfarmers shares?

    Could the listing be a good thing or bad thing for Wesfarmers?

    Read more »

    Team celebrating corporate success screaming with joy.
    Share Market News

    Sigma shares rocket 75% on Chemist Warehouse merger plans

    The market has reacted very positively to merger plans between Sigma and Chemist Warehouse.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $1.30 $0.00 0.00% 6,153,356 $1.30 $1.30 $1.28
    27 Mar 2024 $1.30 $0.04 3.20% 25,616,913 $1.27 $1.32 $1.26
    26 Mar 2024 $1.25 $0.02 1.63% 38,170,354 $1.24 $1.26 $1.23
    25 Mar 2024 $1.23 $0.03 2.50% 4,548,973 $1.22 $1.24 $1.20
    22 Mar 2024 $1.20 $-0.03 -2.44% 4,551,461 $1.25 $1.26 $1.20
    21 Mar 2024 $1.23 $0.01 0.82% 8,960,303 $1.26 $1.28 $1.20
    20 Mar 2024 $1.22 $-0.03 -2.40% 9,830,107 $1.25 $1.28 $1.21
    19 Mar 2024 $1.25 $0.02 1.63% 5,153,187 $1.24 $1.25 $1.22
    18 Mar 2024 $1.23 $0.00 0.00% 1,744,092 $1.23 $1.24 $1.22
    15 Mar 2024 $1.23 $0.01 0.82% 28,509,294 $1.22 $1.23 $1.20
    14 Mar 2024 $1.22 $-0.02 -1.61% 2,757,897 $1.23 $1.24 $1.21
    13 Mar 2024 $1.24 $-0.01 -0.80% 6,799,649 $1.25 $1.29 $1.24
    12 Mar 2024 $1.25 $0.04 3.32% 2,015,745 $1.22 $1.25 $1.21
    11 Mar 2024 $1.21 $-0.01 -0.82% 1,883,043 $1.22 $1.22 $1.20
    08 Mar 2024 $1.22 $0.03 2.53% 6,979,392 $1.19 $1.23 $1.19
    07 Mar 2024 $1.19 $0.04 3.48% 4,384,223 $1.16 $1.19 $1.16
    06 Mar 2024 $1.15 $0.00 0.00% 4,178,482 $1.15 $1.16 $1.13
    05 Mar 2024 $1.15 $0.00 0.00% 3,237,998 $1.16 $1.16 $1.14
    04 Mar 2024 $1.15 $0.02 1.78% 2,888,498 $1.15 $1.17 $1.13
    01 Mar 2024 $1.13 $-0.02 -1.75% 2,677,482 $1.14 $1.15 $1.12
    29 Feb 2024 $1.15 $0.02 1.79% 13,446,625 $1.12 $1.15 $1.12
    28 Feb 2024 $1.12 $0.01 0.90% 3,487,342 $1.12 $1.12 $1.11

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    29 Jan 2024 Neville Mitchell Issued 6,474 $4,531
    Rights issue.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 111,548 $78,083
    Rights issue.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 129,730 $90,811
    Rights issue.
    29 Jan 2024 Michael Sammells Issued 81,444 $57,010
    Rights issue.
    29 Jan 2024 Annette Carey Issued 3,708 $2,595
    Rights issue.
    10 Jan 2024 Annette Carey Buy 4,697 $4,461
    Directors' share plan.
    10 Jan 2024 Michael Sammells Buy 10,612 $10,079
    Directors' share plan.
    10 Jan 2024 Kathryn (Kate) Spargo Buy 5,442 $5,169
    Directors' share plan.
    10 Jan 2024 Christopher Roberts Buy 4,696 $4,460
    Directors' share plan.
    10 Jan 2024 Neville Mitchell Buy 5,566 $5,286
    Directors' share plan.
    20 Dec 2023 Vikesh Ramsunder Exercise 1,482,423 $1,467,598
    Conversion of securities. 48,35,167 Rights
    20 Dec 2023 Vikesh Ramsunder Issued 1,482,423 $1,467,598
    Conversion of securities.
    10 Jul 2023 Annette Carey Buy 5,489 $4,460
    Directors' share plan.
    10 Jul 2023 Neville Mitchell Buy 5,490 $4,461
    Directors' share plan.
    10 Jul 2023 Kathryn (Kate) Spargo Buy 7,116 $5,782
    Directors' share plan.
    10 Jul 2023 Michael Sammells Buy 11,792 $9,582
    Directors' share plan.
    10 Jul 2023 Christine Bartlett Buy 6,506 $5,286
    Directors' share plan.
    13 Jun 2023 Vikesh Ramsunder Issued 3,112,283 $2,614,317
    Issue of securities. 63,17,590 Rights
    18 Apr 2023 Vikesh Ramsunder Issued 240,462 $170,728
    Issue of securities. 32,05,307 rights
    18 Apr 2023 Michael Sammells Buy 13,496 $9,582
    Directors' share plan.
    18 Apr 2023 David Manuel Buy 6,981 $4,956
    Directors' share plan.
    18 Apr 2023 Christine Bartlett Buy 7,446 $5,286
    Directors' share plan.
    18 Apr 2023 Kathryn (Kate) Spargo Buy 8,144 $5,782
    Directors' share plan.
    18 Apr 2023 Neville Mitchell Buy 4,091 $2,904
    Directors' share plan.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts has more than 40 years experience in the medical device industry, including as the former CEO of Cochlear Limited (ASX:COH) from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He is currently a Non-Executive Director of: HMC Capital managed HealthCo Healthcare and Wellness REIT (ASX: HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell has financial experience coupled with more than a decade of experience as an active Nonexecutive Director. He is a current Director and Chair of the Audit Committee of Sonic Healthcare and is a Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare and QBiotics. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.
    Ms Kathryn (Kate) Dianne Spargo Non-Executive Director Dec 2015
    Ms Spargo has gained business experience as both an adviser, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently Non-Executive Director at Sonic Healthcare Limited, Adairs Limited, and CIMIC Ltd. Ms Spargo has held as Non-Executive Director in Xenith IP Ltd and Fletcher Building Limited. In addition, Ms Spargo's current positions in unlisted companies include Chairman of CoInvest and Director at the Geelong Football Club and Future Fuels Cooperative Research Centre. She is a Member of Risk Management and People committee.
    Mr Michael Sammells Non-Executive DirectorInterim Chairman Feb 2020
    Mr Sammells is currently a NonExecutive Director at AMP. Mr Sammells has 35 years of experience in finance, corporate services, and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private. He is a Chair of Risk Management Committee.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder was previously Group CEO of Clicks Group in South Africa, a position he held since January 2019. Prior to becoming Group CEO, Vikesh held a number of roles within the Clicks Group, including Chief Operating Officer from 2015, and Managing Director of United Pharmaceutical Distributors (UPD), the Click Group's pharmaceutical wholesale and distribution division.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is a current Director of National Intermodal Corporation and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global and BevChain. Ms Carey brings a technical as well as strategic and commercial intellect from over 20 years experience in transport, supply chain and logistics. Ms Carey has previously held various senior roles within Linfox, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post.
    Ms Kara McGowan General CounselCompany Secretary Oct 2021
    -
    Kara McGowan General CounselCompany Secretary
    -
    Kara McGowan General Counsel & Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hmc Capital Partners Holdings Pty Ltd 202,034,368 19.07%
    Citicorp Nominees Pty Limited 182,778,084 17.25%
    Hsbc Custody Nominees (Australia) Limited 118,845,999 11.22%
    J P Morgan Nominees Australia Pty Limited 83,059,531 7.84%
    Pacific Custodians Pty Limited 35,188,143 3.32%
    Sigma Employee Share Admin P/L 33,222,595 3.14%
    Ubs Nominees Pty Ltd 28,607,742 2.70%
    Hsbc Custody Nominees (Australia) Limited Nt- Comnwlth Super Corp 17,579,895 1.66%
    National Nominees Limited 17,135,773 1.62%
    Hsbc Custody Nominees (Australia) Limited A/C 2 9,811,532 0.93%
    Bnp Paribas Noms Pty Ltd 9,271,084 0.88%
    Mr Mark Robert Hooper 8,990,863 0.85%
    Invia Custodian Pty Limited 7,596,480 0.72%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 5,300,285 0.50%
    De Fazio Capital Pty Ltd 5,000,000 0.47%
    Netwealth Investments Limited 3,223,629 0.30%
    Citicorp Nominees Pty Limited i 2,609,335 0.25%
    Alphagen Capital Pty Ltd 2,500,000 0.24%
    Mr Jeffrey Sells 2,400,021 0.23%
    Bnp Paribas Nominees Pty Ltd Acf Clearstream 2,280,888 0.22%

    Profile

    since

    Note